What Is a Washout Period?
A washout period is a planned treatment-free interval used before or between study periods to reduce carryover effects, protect participants or make results easier to interpret. Its length is product- and protocol-specific.
The important distinctions
A washout period is a planned treatment-free interval used before or between study periods to reduce carryover effects, protect participants or make results easier to interpret. Its length is product- and protocol-specific.
More than half-life
Investigators consider active metabolites, biological effects, toxicity recovery and interaction risk—not only plasma concentration.
Designed for the study
A crossover trial may need washout so the first intervention does not affect the second period.
Ethics can limit washout
Stopping effective treatment may be unsafe, so modern guidance discourages unnecessary or overly restrictive washouts.
What the evidence actually shows
After one, two and three half-lives, approximately 50%, 25% and 12.5% remain when elimination is first-order.
View source ↗After five half-lives, roughly 96.875% has been eliminated. FDA has used five half-lives as a general trial starting point, while allowing shorter periods when scientifically justified.
View source ↗A washout estimate fails when the vial identity, half-life, active metabolites or biological effects are uncertain. Symptom disappearance is not proof of clearance.
View source ↗Grey-market boundary: Evidence from an approved product or published formulation is a useful anchor, not automatic validation of a vendor vial with unknown excipients, fill accuracy, sterility or storage history.
Two contexts people often combine
Scientific purpose
Washout can reduce carryover and clarify which intervention produced an observed outcome.
Participant safety
It may allow adverse effects or laboratory changes to resolve, but withholding treatment can create its own risk.
What to verify
- 1
Read the protocol definition and which treatments it covers.
- 2
Check whether the interval is based on time, recovery criteria or both.
- 3
Confirm which rescue or concomitant medicines remain allowed.
- 4
Never stop prescribed medicine to imitate a research washout without the prescriber.
Five half-lives is only a rough pharmacokinetic rule. A drug’s biological effect can end sooner or persist longer than measurable blood concentrations.
Quick follow-ups
Does washout mean every molecule is gone?
No. It aims to reduce clinically meaningful carryover to an acceptable level, not prove absolute zero.
Why are washout rules changing in trials?
FDA guidance notes that unnecessarily long exclusions can reduce access and diversity without improving safety or interpretation.
Guidance and evidence
- FDA: clinical-trial washout periods (2024)Draft guidance · fda.gov↗
- FDA: patient-friendly clinical-trial termsOfficial glossary · fda.gov↗
- Elimination half-life of drugs (2025)Clinical reference · ncbi.nlm.nih.gov↗
Bring a source or ask a focused question in Research Discussions.
Visit Research Discussions